0001209191-21-022309.txt : 20210322
0001209191-21-022309.hdr.sgml : 20210322
20210322160009
ACCESSION NUMBER: 0001209191-21-022309
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210318
FILED AS OF DATE: 20210322
DATE AS OF CHANGE: 20210322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BREITMEYER JAMES B
CENTRAL INDEX KEY: 0001244823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 21761300
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-18
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001244823
BREITMEYER JAMES B
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
1
0
0
Chief Executive Officer
Stock Options
0.81
2021-03-18
4
A
0
63295
0.00
A
2028-11-14
Common Stock
63295
105492
D
On November 14, 2018, the reporting person was granted an award of stock options that vest upon the achievement of certain pre-established strategic milestones. On March 18, 2021, the Compensation Committee of the Issuers board of directors determined that certain of the strategic milestones have been achieved, resulting in the vesting of options to purchase 63,295 shares of the Issuers common stock.
/s/ Richard G. Vincent, Attorney-in-fact
2021-03-22